Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Introducing CLipPA lipid chemodiversity to enzymatically truncated polymyxin B: a soft drug strategy to combat Gram-negative pathogens.
Journal: RSC medicinal chemistry
Published: December 18, 2025
mRNA vaccine against malaria tailored for liver-resident memory T cells.
Journal: Nature immunology
Published: November 30, 2022
Synthesis, Antibacterial Activity, and Nephrotoxicity of Polymyxin B Analogues Modified at Leu-7, d-Phe-6, and the N-Terminus Enabled by S-Lipidation.
Journal: ACS infectious diseases
Published: November 22, 2022
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma.
Journal: Cancer immunology, immunotherapy : CII
Published: February 21, 2022
6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria.
Journal: RSC chemical biology
Published: December 24, 2021
Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist.
Journal: Organic & biomolecular chemistry
Published: January 19, 2019
Biologically Active Acetylenic Amino Alcohol and N-Hydroxylated 1,2,3,4-Tetrahydro-β-carboline Constituents of the New Zealand Ascidian Pseudodistoma opacum.
Journal: Journal of natural products
Published: December 17, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026